1. Home
  2. INSG vs ELOX Comparison

INSG vs ELOX Comparison

Compare INSG & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inseego Corp.

INSG

Inseego Corp.

HOLD

Current Price

$4.33

Market Cap

59.2M

ML Signal

HOLD

Logo Eloxx Pharmaceuticals Inc. Common Stock

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

HOLD

Current Price

$14.54

Market Cap

60.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSG
ELOX
Founded
1996
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
59.2M
60.3M
IPO Year
2000
2013

Fundamental Metrics

Financial Performance
Metric
INSG
ELOX
Price
$4.33
$14.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$13.67
★ $38.25
AVG Volume (30 Days)
★ 331.9K
18.3K
Earning Date
11-05-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 41.67
EPS
★ 0.13
N/A
Revenue
★ $313,832,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.21
N/A
P/E Ratio
$35.19
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.58
$10.00
52 Week High
$21.90
$23.40

Technical Indicators

Market Signals
Indicator
INSG
ELOX
Relative Strength Index (RSI) 47.44 39.85
Support Level $3.96 $13.92
Resistance Level $4.61 $14.65
Average True Range (ATR) 0.27 1.32
MACD 0.10 -0.18
Stochastic Oscillator 57.10 21.45

Price Performance

Historical Comparison
INSG
ELOX

About INSG Inseego Corp.

Inseego Corp is involved in the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things, and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by application software and cloud services designed to enable customers to analyze data insights and configure and manage their hardware easily. It generates maximum revenue from the United States and Canada. The company also has a presence in Europe (including the United Kingdom).

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Share on Social Networks: